glycemic control, we found that BED is more common in this group than in the general population, i.e., 5.26%. This result confirms the results of previous studies that reported the prevalence of BED in T2DM patients as 2.5%–25.6%.
glycemic control, we found that BED is more common in this group than in the general population, i.e., 5.26%. This result confirms the results of previous studies that reported the prevalence of BED in T2DM patients as 2.5%–25.6%.